<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01582828</url>
  </required_header>
  <id_info>
    <org_study_id>SHAFT-01</org_study_id>
    <nct_id>NCT01582828</nct_id>
  </id_info>
  <brief_title>Serial Hybrid Atrial Fibrillation Ablation</brief_title>
  <acronym>SHAFT</acronym>
  <official_title>Serial Hybrid Atrial Fibrillation Ablation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medisch Spectrum Twente</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medisch Spectrum Twente</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Treatment of (long-standing) persistent atrial fibrillation (AF) remains cumbersome and the
      surgical (epicardial) approach seems to be the most effective. Still, however a significant
      amount of failures exist which is mostly due to incompleteness of the surgical ablation
      lines. Checking, and if necessary additional ablation, of these lines afterwards
      endocardially by the cardiologist (the so-called serial hybrid approach) could overcome this
      problem.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Atrial fibrillation Freedom</measure>
    <time_frame>12 months</time_frame>
    <description>left sided atrial flutter and left atrial tachycardia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>re-isolation</measure>
    <time_frame>8-10 weeks</time_frame>
    <description>number of pulmonary veins needing re-isolation by the EP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of cross-over</measure>
    <time_frame>1 year</time_frame>
    <description>Percentage of cross-over from the surgical arm alone to surgery and serial hybrid ablation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>1 year</time_frame>
    <description>Number of complications and thrombo-embolic events in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atrial fibrillation Burden</measure>
    <time_frame>1 year</time_frame>
    <description>Burden of AF in both groups if AF is still present.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">162</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Epicardial (surgical) ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Epicardial Pulmonary vein isolation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hybrid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epicardial (surgical) ablation &amp; Endocardial assessment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Epicardial (surgical) ablation</intervention_name>
    <description>Pulmonary vein isolation with bipolar clamps and bipolar box lesion
Epicardial atrial appendage closure</description>
    <arm_group_label>Epicardial (surgical) ablation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hybrid</intervention_name>
    <description>Epicardial (surgical) ablation
Pulmonary vein isolation with bipolar clamps and bipolar box lesion
Epicardial atrial appendage closure
Endocardial assessment after 6-8 weeks, checking for isolation and if necessary touch up by RF ablation</description>
    <arm_group_label>Hybrid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients are screened and accepted for pulmonary vein isolation according to the
             current guidelines

          -  long standing persistent or persistent AF as defined in the guidelines

          -  left atrial size needs to be more than &gt;46 mm on long axis or &gt;35 cc/m2

          -  CHADSVASC score should be more than 0 as an indicator of a substantial substrate for
             atrial fibrillation.

        Exclusion Criteria:

          -  Significant coronary artery disease has to be excluded as a trigger for AF by means of
             cardiac CT, if necessary a coronary angiogram will be performed.

          -  Previous PVI ablation (epicardial or endocardial) or cardiac surgery.

          -  Significant valvular disease present on echo.

          -  Concomitant cardiac surgery needed.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jurren van Opstal, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medisch Spectrum Twente</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jurren van Opstal, MD PhD</last_name>
    <phone>+31534872110</phone>
    <email>cardiologen@mst.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Harald Verheij</last_name>
    <phone>+31534872108</phone>
    <email>h.verheij@mst.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Medisch Spectrum Twente</name>
      <address>
        <city>Enschede</city>
        <state>OV</state>
        <zip>7500AB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jurren van Opstal, MD PhD</last_name>
      <phone>+31534872110</phone>
      <email>cardiologen@mst.nl</email>
    </contact>
    <contact_backup>
      <last_name>Harald Verheij</last_name>
      <phone>+31534872108</phone>
      <email>h.verheij@mst.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Bob Oude Velthuis, MD MSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2012</study_first_submitted>
  <study_first_submitted_qc>April 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2012</study_first_posted>
  <last_update_submitted>July 6, 2016</last_update_submitted>
  <last_update_submitted_qc>July 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medisch Spectrum Twente</investigator_affiliation>
    <investigator_full_name>B. Oude Velthuis</investigator_full_name>
    <investigator_title>Research fellow electrophysiology</investigator_title>
  </responsible_party>
  <keyword>atrial</keyword>
  <keyword>fibrillation</keyword>
  <keyword>pvi</keyword>
  <keyword>vats</keyword>
  <keyword>ablation</keyword>
  <keyword>hybrid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

